BPC-157BPC
Healing & Recovery
Synthetic gastric peptide studied in research for tissue-healing and cytoprotective properties
Not established in human PK data; preclinical data suggest short plasma half-life with local tissue accumulation200–600 mcg
TB-500TB
Healing & Recovery
Synthetic thymosin beta-4 fragment studied for tissue repair and regeneration
Unknown; preclinical data suggests hours to days500–1000 mcg once daily
IpamorelinIPA
Growth Hormone
Selective growth hormone secretagogue studied for minimal off-target hormonal effects
1.5–2.5 hours100–250 mcg
CJC-1295 (no DAC)CJC
Growth Hormone
CJC-1295 NO DAC (5 mg Vial) — Dosing Studied in Research
~30 minutes100-300 mcg
GHK-CuGHK
Skin & Anti-Aging
Copper-binding tripeptide studied for skin regeneration, wound healing, and tissue repair
Unknown; research-grade protocols based on empirical use1.0–2.0 mg per injection
SemaglutideSEMA
Metabolic
Once-Weekly GLP-1 Agonist for Weight Management & Glycemic Control
~7 days250–2400 mcg weekly
TirzepatideTIRZ
Metabolic
Dual GLP-1 / GIP Incretin Receptor Agonist for Metabolic & Weight Management
~5 days2.5–15 mg once weekly
RetatrutideRETA
Metabolic
Triple-receptor agonist studied for weight loss and metabolic health
~6 days (once-weekly dosing)2–12 mg weekly
PT-141 (Bremelanotide)PT
Vitality
Central melanocortin agonist studied for sexual desire and arousal
~2.7 hours (bremelanotide)500–1500 mcg
NAD+NAD
Vitality
Studied for cellular energy, DNA repair, and mitochondrial resilience through NAD+ replenishment
Not well established for SC route; IV half-life is short (minutes to a few hours)50–100 mg once daily
5-Amino-1MQ5A1MQ
Metabolic
Selective NNMT inhibitor studied for fat metabolism and NAD+ elevation
Approximately 3.8–6.9 hours2.5–5 mg once or twice daily (subcutaneous)
AdamaxADX
Cognitive & Nootropic
Adamantane-Modified Semax Analog Studied for Cognitive & Neuroprotective Research
Extended vs. standard Semax due to adamantane modification (prolonged in vivo half-life)500–1000 µg daily
AdipotideADP
Metabolic
Vascular-targeted pro-apoptotic peptide investigated in white adipose tissue research
Not established in humans250–1000 mcg daily
AICARAICAR
Metabolic
The "Exercise Pill" — Studied as an AMPK Activator & Metabolic Modulator
Short (hours; specific half-life not established for subcutaneous research dosing)1,000–3,000 mcg daily (conservative); up to 5,000 mcg in advanced protocols
AOD-9604AOD
Metabolic
Synthetic hGH C-terminal fragment studied for lipolysis without IGF-1 elevation
Not established in published literature for subcutaneous dosing300-500 mcg daily
Ara-290 (Cibinetide)ARA
Healing & Recovery
Educational guide to research reconstitution and dosing
Not specified2–4 mg daily
CagrilintideCAGRI
Metabolic
Long-acting amylin analogue studied for once-weekly weight management
Approximately 160–195 hours0.25–2.4 mg weekly
CartalaxCART
Bioregulator
Synthetic tripeptide bioregulator studied for connective tissue and extracellular matrix
Not established in published literature; ultrashort peptides are generally subject to rapid proteolytic degradation2,000–5,000 mcg daily
CerebrolysinCERE
Cognitive & Nootropic
Neurotrophic peptide preparation studied for neuronal survival and neuroprotection
Short; clinical literature supports once- or twice-daily subcutaneous dosing20–32 mg daily
ChonlutenCHON
Bioregulator
Bronchopulmonary bioregulatory tripeptide (Glu-Asp-Gly)
Not established (short peptide; rapid systemic clearance expected)250–4,000 mcg once daily
CJC-1295 DACCJC-DAC
Growth Hormone
Long-acting GHRH analog with albumin-binding DAC technology studied for once-weekly dosing
6–8 days1000–2000 mcg per week
CortagenCORT
Bioregulator
Neuroprotective tetrapeptide bioregulator studied for nerve regeneration and cognition
Not established in published literature1000–2000 mcg daily
Delta Sleep-Inducing PeptideDSIP
Sleep & Recovery
Naturally occurring nonapeptide studied for slow-wave sleep support and stress modulation
Not established in published literature100–500 mcg daily (typical 100–300 mcg; advanced up to 500 mcg)
Epitalon (Epithalon)EPI
Longevity
Synthetic tetrapeptide studied for telomerase activation and geroprotection
Not established in published human pharmacokinetic data5,000 mcg (5 mg) once daily; alternative: 10 mg/day for 10 days (same total 100 mg cycle dose)
FOXO4-DRIFOXO4
Longevity
Senolytic peptide studied for the selective clearance of senescent "zombie" cells
Not established in humans250–500 mcg daily with gradual escalation
GHRP-2GHRP-2
Growth Hormone
GH secretagogue studied for pulsatile release
~15–30 minutes (plasma elimination); GH response peak ~30–60 minutes post subcutaneous injection100–300 mcg daily
GHRP-6GHRP-6
Growth Hormone
GH secretagogue studied for pulsatile release via ghrelin receptor activation
~2.5 hours100–300 mcg per injection
GlutathioneGSH
Skin & Anti-Aging
Antioxidant tripeptide studied for cellular detoxification and redox balance
Short; exact subcutaneous half-life not well established in literature100–200 mg daily
GonadorelinGnRH
Hormonal & Fertility
Synthetic GnRH studied for HPG axis function and fertility research
2–10 minutes (endogenous GnRH); synthetic gonadorelin cleared rapidly after each pulsatile dose50–250 mcg per injection
Human Chorionic GonadotropinHCG
Hormonal & Fertility
LH-mimetic glycoprotein hormone studied for testicular maintenance and fertility research
36 hours500–2500 IU per injection
HGH 191AAHGH
Growth Hormone
Recombinant human growth hormone identical to endogenous GH — studied for body composition, metabolic regulation, and tissue repair.
~20–30 minutes (IV); ~2–4 hours (subcutaneous)150–500 mcg/day (conservative) to 1000–2000 mcg/day (advanced protocols)
Human Menopausal GonadotropinHMG
Hormonal & Fertility
HMG (0.15 mg / 75 IU Vial) — Study-Referenced Dosing Overview
~24-36 hours (FSH component); LH component shorter75-150 IU
IGF-1 LR3IGF
Growth Hormone
Long-acting IGF-1 analog with extended half-life, studied in anabolic and metabolic research
Several hours (extended from minutes for native IGF-1)20–50 mcg
Kisspeptin-10KISS
Hormonal & Fertility
Upstream signal studied in the reproductive hormone cascade
~4 minutes100–200 mcg daily
KPVKPV
Healing & Recovery
C-terminal tripeptide fragment of alpha-MSH studied for anti-inflammatory activity without melanotropic effects
Not established in published human pharmacokinetic studies200–500 mcg daily
L-CarnitineLCAR
Metabolic
Mitochondrial fatty acid transporter studied for fat oxidation and energy production
Not specified on source page; plasma half-life of L-Carnitine is approximately 17 hours50–200 mg/day
LivagenLIV
Bioregulator
Synthetic tetrapeptide bioregulator studied for peptidase inhibition and epigenetic modulation in aging tissues.
Not established; estimated ~30 minutes based on tetrapeptide pharmacokinetic inference (no formal studies published)0.5–2.0 mg daily with gradual titration
LL-37LL-37
Healing & Recovery
Human cathelicidin antimicrobial peptide studied for wound healing and immune modulation
Short; exact subcutaneous half-life not established in peer-reviewed literature — once-daily dosing used in protocols100–400 mcg per day
MazdutideMAZ
Metabolic
Long-acting dual GLP-1/glucagon receptor agonist studied for weight management and metabolic health
Approximately 7 days (once-weekly dosing)2.5–6 mg weekly (advanced protocols may reach 10 mg)
Melanotan IIMT-II
Vitality
Synthetic melanocortin agonist studied for skin pigmentation and sexual function
1–2 hours250–1000 mcg
Mechano Growth FactorMGF
Growth Hormone
IGF-1 Splice Variant Studied for Muscle Repair & Satellite Cell Activation
Approximately 5–7 minutes (unmodified); PEGylated forms have extended half-life of several hours100–300 mcg once daily
MOTS-CMOTS-C
Metabolic
Mitochondrial-derived peptide studied for metabolic homeostasis, insulin sensitivity, and healthy aging
Estimated 1–2 hours based on endogenous exercise-induced levels returning to baseline within 4 hours; formal human pharmacokinetic data not yet established500–2000 mcg per day (titrated; typical maintenance 500–1500 mcg)
OvagenOVA
Bioregulator
Synthetic ultrashort tripeptide bioregulator studied for gastrointestinal and liver tissue support
Not established (ultrashort peptide; rapidly metabolized)10–150 mcg once daily
OxytocinOXT
Vitality
The Social Bonding Peptide — Studied for Trust, Calm & Connection
Short — approximately a few minutes in plasma; central effects may persist longer via receptor binding100–500 mcg
PE-22-28PE
Cognitive & Nootropic
TREK-1 antagonist studied for antidepressant and neuroplasticity effects
~23 hours50–200 µg daily; 100–150 µg commonly considered adequate
PEG MGFPEG-MGF
Growth Hormone
PEGylated Mechano Growth Factor Studied for Muscle Repair and Satellite Cell Activation
Extended (multi-day) due to PEGylation; once-daily dosing supported200–500 mcg once daily
PinealonPIN
Bioregulator
Neuroprotective tripeptide bioregulator studied for cognitive health and brain longevity
Not established in published literature; short peptide half-lives are typical for tripeptides1.0–2.0 mg once daily
PNC-27PNC
Longevity
Synthetic p53-derived peptide studied preclinically for selective cancer-cell cytotoxicity
Not established (no published human pharmacokinetic data)100–500 mcg once daily
ProstamaxPROST
Bioregulator
Prostamax is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Pro / KEDP) derived from prostate tissue peptide complex research.
Not established in published human data500 mcg–1 mg daily with gradual titration
SelankSEL
Cognitive & Nootropic
Selank is a synthetic heptapeptide analog of tuftsin studied for anxiolytic and anti-asthenic (energy-related) properties in human clinical trials.
~2–10 min plasma half-life; pharmacodynamic effects persist 12–24 hours300–500 mcg
SemaxSEM
Cognitive & Nootropic
Neuroprotective heptapeptide analog of ACTH(4–10) studied for cognitive and cerebrovascular research
Short biological half-life; subcutaneous delivery provides more sustained systemic absorption than intranasal dosing200–500 mcg once daily
SermorelinSERM
Growth Hormone
Studied for endogenous GH stimulation via pituitary GHRH activation
~10–20 minutes (active pulsatile GH secretion lasting several hours)200–500 mcg daily
SLU-PP-332SLU
Metabolic
PRECLINICAL RESEARCH COMPOUND: Pan-ERR agonist studied as an exercise mimetic
Unknown — not established in human or preclinical pharmacokinetic studies1250–2500 mcg daily (divided doses, murine-equivalent)
SNAP-8SNAP-8
Skin & Anti-Aging
Topical-grade octapeptide studied for relaxing expression muscles to smooth dynamic wrinkles without paralysis.
Not established (topical/local peptide; systemic half-life data not available)330–1,000 mcg daily
SS-31 (Elamipretide)SS-31
Longevity
Mitochondria-targeted tetrapeptide studied for stabilizing the inner membrane and supporting cellular energy output.
~2–4 hours (based on pharmacokinetic data from clinical studies)5–20 mg/day
SurvodutideSURVO
Metabolic
Dual GLP-1/glucagon receptor agonist studied for obesity and metabolic liver disease
~7 days (once-weekly dosing)0.6–6.0 mg once weekly
TesamorelinTESA
Growth Hormone
FDA-approved GHRH analog studied for visceral fat reduction and metabolic health
~26–38 minutes (endogenous GH pulse duration; IGF-1 elevation sustained over 24 hours)1000–2000 mcg/day
TestagenTEST
Bioregulator
Anterior pituitary tetrapeptide bioregulator studied for endocrine and pituitary–gonadal axis research
Not established in human studies100–300 mcg daily
Thymosin Alpha-1TA1
Immune
Thymic immunomodulator studied for T-cell support and host defense research
~2–3 hours300–500 mcg daily
Vesugen (Lys-Glu-Asp)VES
Bioregulator
Tripeptide vascular bioregulator studied for endothelial cell renewal and Ki-67 gene expression
Not established in published literature; short-chain tripeptides typically have rapid systemic clearance500–2000 mcg once daily
VilonVIL
Bioregulator
Immunoregulatory dipeptide studied for immune cell markers and aging
Not established in published literature67–670 mcg daily